Activation of src kinases, second messengers of HER2, exhibit increased Src protein levels and protein kinase activity in many human tumor tissues when combined with EGFR, to yield a synergistic tumorigenic effect[147]. The gene discussed is ERBB2; the disease is neoplasm.